Key findings
- Thermo Fisher has announced a partnership with NVIDIA to bring AI and automation to the lab.
- Thermo Fisher will integrate NVIDIA’s AI infrastructure and models, including NVIDIA DGX Spark, NeMo, and BioNeMo.
Thermo Fisher Scientific has announced a new partnership with NVIDIA to build out AI-based solutions and laboratory automation “at scale”.
The problem with today’s labs
Many core lab tasks are still manual, including designing experiments, setting up instruments, preparing samples, running assays, and interpreting results.
The new tech stack
To automate some of that process, Thermo Fisher will combine its instruments and software with NVIDIA’s AI infrastructure, including NVIDIA DGX Spark and models such as NVIDIA NeMo and NVIDIA BioNeMo.
BioNeMo has been used by San Diego biotech company, BrainStorm Therapeutics, to speed up stem cell derived brain organoid development. (note – not Brainstorm Cell Therapeutics, the company behind NurOwn)
This tracks with the recent FDA guidance on AI drug development, released just a few days after this announcement.
The end goal appears to be to build a digital foundation across lab instruments, infrastructure, and data so the workflow can work more seamlessly and intuitively, a process called “lab-in-the-loop”.
“Artificial intelligence coupled with laboratory automation will transform how scientific work is performed,” said Gianluca Pettiti, Executive Vice President. “By combining Thermo Fisher’s leadership in laboratory technologies with NVIDIA’s digital and AI solutions, we can help customers work faster, improve accuracy and get more value out of each experiment, ultimately accelerating discoveries that can have significant human impact.”
“We are entering the era of ‘lab-in-the-loop’ science where the trinity of AI, agents and instruments will be able to scale scientific discovery at industrial pace,” said Kimberly Powell, Vice President of Healthcare at NVIDIA. “Working with Thermo Fisher, we are building the fundamental infrastructure of autonomous labs, creating a powerful research and discovery flywheel accelerating the pace of life sciences breakthroughs.”
Want to keep up on regenerative medicine? Get the weekly newsletter here.
